To further characterize the distribution of cardiomyocyte EV in other patient groups, caveolin-3+ EV were analyzed in 10 patients with stable coronary artery disease and compared to STEMI patients (Supplementary Figure S6). Here, CAV3 is linked to coronary artery disorder.